nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—atherosclerosis	0.402	0.619	CbGaD
Fulvestrant—ESR1—atherosclerosis	0.247	0.381	CbGaD
Fulvestrant—CYP3A4—Rosuvastatin—atherosclerosis	0.0158	0.211	CbGbCtD
Fulvestrant—CYP3A4—Ezetimibe—atherosclerosis	0.0158	0.211	CbGbCtD
Fulvestrant—CYP3A4—Simvastatin—atherosclerosis	0.0147	0.196	CbGbCtD
Fulvestrant—CYP3A4—Pravastatin—atherosclerosis	0.0144	0.192	CbGbCtD
Fulvestrant—CYP3A4—Lovastatin—atherosclerosis	0.0144	0.192	CbGbCtD
Fulvestrant—NR1H4—connective tissue—atherosclerosis	0.00168	0.125	CbGeAlD
Fulvestrant—NR1H4—cardiovascular system—atherosclerosis	0.00146	0.108	CbGeAlD
Fulvestrant—Cough increased—Niacin—atherosclerosis	0.00119	0.0091	CcSEcCtD
Fulvestrant—Injury—Rosuvastatin—atherosclerosis	0.00118	0.00903	CcSEcCtD
Fulvestrant—EPHX2—adipose tissue—atherosclerosis	0.00113	0.0835	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—atherosclerosis	0.00112	0.0829	CbGeAlD
Fulvestrant—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00108	0.0083	CcSEcCtD
Fulvestrant—ESR1—blood vessel—atherosclerosis	0.00103	0.0764	CbGeAlD
Fulvestrant—Hepatic failure—Lovastatin—atherosclerosis	0.00102	0.00783	CcSEcCtD
Fulvestrant—Estradiol—ESR2—atherosclerosis	0.00102	0.529	CrCbGaD
Fulvestrant—Hepatic failure—Ezetimibe—atherosclerosis	0.001	0.00768	CcSEcCtD
Fulvestrant—Injury—Lovastatin—atherosclerosis	0.001	0.00766	CcSEcCtD
Fulvestrant—ESRRA—adipose tissue—atherosclerosis	0.000989	0.0731	CbGeAlD
Fulvestrant—Breast disorder—Rosuvastatin—atherosclerosis	0.000981	0.0075	CcSEcCtD
Fulvestrant—Hot flush—Ezetimibe—atherosclerosis	0.000964	0.00738	CcSEcCtD
Fulvestrant—Hepatic failure—Simvastatin—atherosclerosis	0.000957	0.00732	CcSEcCtD
Fulvestrant—Menopausal symptoms—Ezetimibe—atherosclerosis	0.000956	0.00731	CcSEcCtD
Fulvestrant—Arthritis—Lovastatin—atherosclerosis	0.000946	0.00724	CcSEcCtD
Fulvestrant—Influenza—Rosuvastatin—atherosclerosis	0.000938	0.00718	CcSEcCtD
Fulvestrant—Arthritis—Ezetimibe—atherosclerosis	0.000928	0.0071	CcSEcCtD
Fulvestrant—Pain in extremity—Lovastatin—atherosclerosis	0.00092	0.00704	CcSEcCtD
Fulvestrant—NR1H4—liver—atherosclerosis	0.000906	0.067	CbGeAlD
Fulvestrant—Pain in extremity—Ezetimibe—atherosclerosis	0.000902	0.0069	CcSEcCtD
Fulvestrant—Arthritis—Simvastatin—atherosclerosis	0.000885	0.00677	CcSEcCtD
Fulvestrant—Hepatic failure—Pravastatin—atherosclerosis	0.000865	0.00662	CcSEcCtD
Fulvestrant—Injury—Pravastatin—atherosclerosis	0.000846	0.00647	CcSEcCtD
Fulvestrant—Depression—Rosuvastatin—atherosclerosis	0.000834	0.00638	CcSEcCtD
Fulvestrant—Hot flush—Pravastatin—atherosclerosis	0.000831	0.00636	CcSEcCtD
Fulvestrant—Menopausal symptoms—Pravastatin—atherosclerosis	0.000824	0.00631	CcSEcCtD
Fulvestrant—Breast disorder—Ezetimibe—atherosclerosis	0.000815	0.00624	CcSEcCtD
Fulvestrant—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000813	0.00622	CcSEcCtD
Fulvestrant—Arthritis—Niacin—atherosclerosis	0.000813	0.00622	CcSEcCtD
Fulvestrant—Arthritis—Pravastatin—atherosclerosis	0.0008	0.00612	CcSEcCtD
Fulvestrant—Influenza—Lovastatin—atherosclerosis	0.000795	0.00608	CcSEcCtD
Fulvestrant—EPHX2—liver—atherosclerosis	0.000792	0.0586	CbGeAlD
Fulvestrant—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000791	0.00605	CcSEcCtD
Fulvestrant—Influenza—Ezetimibe—atherosclerosis	0.00078	0.00597	CcSEcCtD
Fulvestrant—ESR2—connective tissue—atherosclerosis	0.000774	0.0572	CbGeAlD
Fulvestrant—Hepatitis—Rosuvastatin—atherosclerosis	0.000751	0.00574	CcSEcCtD
Fulvestrant—Pharyngitis—Rosuvastatin—atherosclerosis	0.000745	0.0057	CcSEcCtD
Fulvestrant—Infestation NOS—Ezetimibe—atherosclerosis	0.000695	0.00532	CcSEcCtD
Fulvestrant—Infestation—Ezetimibe—atherosclerosis	0.000695	0.00532	CcSEcCtD
Fulvestrant—ESRRA—liver—atherosclerosis	0.000694	0.0513	CbGeAlD
Fulvestrant—Urinary tract infection—Lovastatin—atherosclerosis	0.000689	0.00527	CcSEcCtD
Fulvestrant—Influenza—Niacin—atherosclerosis	0.000683	0.00522	CcSEcCtD
Fulvestrant—ESR2—cardiovascular system—atherosclerosis	0.000673	0.0498	CbGeAlD
Fulvestrant—Influenza—Pravastatin—atherosclerosis	0.000672	0.00514	CcSEcCtD
Fulvestrant—Depression—Simvastatin—atherosclerosis	0.000661	0.00506	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000657	0.00503	CcSEcCtD
Fulvestrant—Hepatitis—Lovastatin—atherosclerosis	0.000636	0.00487	CcSEcCtD
Fulvestrant—Estradiol—ESR1—atherosclerosis	0.000627	0.326	CrCbGaD
Fulvestrant—Hepatitis—Ezetimibe—atherosclerosis	0.000624	0.00477	CcSEcCtD
Fulvestrant—Pharyngitis—Ezetimibe—atherosclerosis	0.000619	0.00474	CcSEcCtD
Fulvestrant—Oedema peripheral—Ezetimibe—atherosclerosis	0.000615	0.0047	CcSEcCtD
Fulvestrant—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000613	0.00469	CcSEcCtD
Fulvestrant—Depression—Pravastatin—atherosclerosis	0.000598	0.00457	CcSEcCtD
Fulvestrant—Angioedema—Rosuvastatin—atherosclerosis	0.000597	0.00457	CcSEcCtD
Fulvestrant—Hepatitis—Simvastatin—atherosclerosis	0.000595	0.00455	CcSEcCtD
Fulvestrant—Sweating—Niacin—atherosclerosis	0.000584	0.00447	CcSEcCtD
Fulvestrant—Urinary tract infection—Pravastatin—atherosclerosis	0.000583	0.00446	CcSEcCtD
Fulvestrant—Cough—Rosuvastatin—atherosclerosis	0.00057	0.00436	CcSEcCtD
Fulvestrant—Angiopathy—Ezetimibe—atherosclerosis	0.000566	0.00433	CcSEcCtD
Fulvestrant—Immune system disorder—Ezetimibe—atherosclerosis	0.000564	0.00431	CcSEcCtD
Fulvestrant—Arthralgia—Rosuvastatin—atherosclerosis	0.000556	0.00426	CcSEcCtD
Fulvestrant—Myalgia—Rosuvastatin—atherosclerosis	0.000556	0.00426	CcSEcCtD
Fulvestrant—Haemoglobin—Niacin—atherosclerosis	0.000549	0.0042	CcSEcCtD
Fulvestrant—Haemorrhage—Niacin—atherosclerosis	0.000546	0.00418	CcSEcCtD
Fulvestrant—Hepatitis—Niacin—atherosclerosis	0.000546	0.00418	CcSEcCtD
Fulvestrant—Malnutrition—Ezetimibe—atherosclerosis	0.000543	0.00416	CcSEcCtD
Fulvestrant—Oedema peripheral—Niacin—atherosclerosis	0.000538	0.00412	CcSEcCtD
Fulvestrant—Hepatitis—Pravastatin—atherosclerosis	0.000538	0.00412	CcSEcCtD
Fulvestrant—Back pain—Lovastatin—atherosclerosis	0.000536	0.0041	CcSEcCtD
Fulvestrant—Pharyngitis—Pravastatin—atherosclerosis	0.000534	0.00409	CcSEcCtD
Fulvestrant—Infection—Rosuvastatin—atherosclerosis	0.00053	0.00405	CcSEcCtD
Fulvestrant—ESR1—connective tissue—atherosclerosis	0.00053	0.0392	CbGeAlD
Fulvestrant—Back pain—Ezetimibe—atherosclerosis	0.000525	0.00402	CcSEcCtD
Fulvestrant—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000523	0.004	CcSEcCtD
Fulvestrant—Angioedema—Lovastatin—atherosclerosis	0.000506	0.00387	CcSEcCtD
Fulvestrant—Anaemia—Ezetimibe—atherosclerosis	0.000502	0.00384	CcSEcCtD
Fulvestrant—Vertigo—Lovastatin—atherosclerosis	0.000498	0.00381	CcSEcCtD
Fulvestrant—Angioedema—Ezetimibe—atherosclerosis	0.000496	0.0038	CcSEcCtD
Fulvestrant—Angiopathy—Niacin—atherosclerosis	0.000496	0.00379	CcSEcCtD
Fulvestrant—Leukopenia—Lovastatin—atherosclerosis	0.000496	0.00379	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000486	0.00372	CcSEcCtD
Fulvestrant—Insomnia—Rosuvastatin—atherosclerosis	0.000482	0.00369	CcSEcCtD
Fulvestrant—Paraesthesia—Rosuvastatin—atherosclerosis	0.000479	0.00366	CcSEcCtD
Fulvestrant—Anaemia—Simvastatin—atherosclerosis	0.000479	0.00366	CcSEcCtD
Fulvestrant—Malnutrition—Niacin—atherosclerosis	0.000476	0.00364	CcSEcCtD
Fulvestrant—Cough—Ezetimibe—atherosclerosis	0.000474	0.00363	CcSEcCtD
Fulvestrant—Angioedema—Simvastatin—atherosclerosis	0.000473	0.00362	CcSEcCtD
Fulvestrant—Myalgia—Lovastatin—atherosclerosis	0.000471	0.00361	CcSEcCtD
Fulvestrant—Chest pain—Lovastatin—atherosclerosis	0.000471	0.00361	CcSEcCtD
Fulvestrant—Arthralgia—Lovastatin—atherosclerosis	0.000471	0.00361	CcSEcCtD
Fulvestrant—Anxiety—Lovastatin—atherosclerosis	0.00047	0.0036	CcSEcCtD
Fulvestrant—Dyspepsia—Rosuvastatin—atherosclerosis	0.000469	0.00359	CcSEcCtD
Fulvestrant—Vertigo—Simvastatin—atherosclerosis	0.000465	0.00356	CcSEcCtD
Fulvestrant—Leukopenia—Simvastatin—atherosclerosis	0.000464	0.00355	CcSEcCtD
Fulvestrant—Myalgia—Ezetimibe—atherosclerosis	0.000462	0.00354	CcSEcCtD
Fulvestrant—Arthralgia—Ezetimibe—atherosclerosis	0.000462	0.00354	CcSEcCtD
Fulvestrant—Chest pain—Ezetimibe—atherosclerosis	0.000462	0.00354	CcSEcCtD
Fulvestrant—ESR1—cardiovascular system—atherosclerosis	0.000461	0.0341	CbGeAlD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000459	0.00351	CcSEcCtD
Fulvestrant—Pain—Rosuvastatin—atherosclerosis	0.000456	0.00349	CcSEcCtD
Fulvestrant—Constipation—Rosuvastatin—atherosclerosis	0.000456	0.00349	CcSEcCtD
Fulvestrant—Infection—Lovastatin—atherosclerosis	0.000449	0.00344	CcSEcCtD
Fulvestrant—Chest pain—Simvastatin—atherosclerosis	0.000441	0.00337	CcSEcCtD
Fulvestrant—Myalgia—Simvastatin—atherosclerosis	0.000441	0.00337	CcSEcCtD
Fulvestrant—Arthralgia—Simvastatin—atherosclerosis	0.000441	0.00337	CcSEcCtD
Fulvestrant—Infection—Ezetimibe—atherosclerosis	0.00044	0.00337	CcSEcCtD
Fulvestrant—Anxiety—Simvastatin—atherosclerosis	0.000439	0.00336	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000436	0.00334	CcSEcCtD
Fulvestrant—Nervous system disorder—Ezetimibe—atherosclerosis	0.000435	0.00333	CcSEcCtD
Fulvestrant—Angioedema—Niacin—atherosclerosis	0.000435	0.00333	CcSEcCtD
Fulvestrant—Anaemia—Pravastatin—atherosclerosis	0.000433	0.00331	CcSEcCtD
Fulvestrant—Anorexia—Lovastatin—atherosclerosis	0.000431	0.0033	CcSEcCtD
Fulvestrant—Skin disorder—Ezetimibe—atherosclerosis	0.000431	0.0033	CcSEcCtD
Fulvestrant—Angioedema—Pravastatin—atherosclerosis	0.000428	0.00327	CcSEcCtD
Fulvestrant—Vertigo—Niacin—atherosclerosis	0.000427	0.00327	CcSEcCtD
Fulvestrant—Leukopenia—Niacin—atherosclerosis	0.000426	0.00326	CcSEcCtD
Fulvestrant—Urticaria—Rosuvastatin—atherosclerosis	0.000424	0.00324	CcSEcCtD
Fulvestrant—Abdominal pain—Rosuvastatin—atherosclerosis	0.000422	0.00323	CcSEcCtD
Fulvestrant—Vertigo—Pravastatin—atherosclerosis	0.000421	0.00322	CcSEcCtD
Fulvestrant—Infection—Simvastatin—atherosclerosis	0.00042	0.00321	CcSEcCtD
Fulvestrant—Leukopenia—Pravastatin—atherosclerosis	0.000419	0.00321	CcSEcCtD
Fulvestrant—ESR2—liver—atherosclerosis	0.000416	0.0308	CbGeAlD
Fulvestrant—Cough—Niacin—atherosclerosis	0.000415	0.00318	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000412	0.00315	CcSEcCtD
Fulvestrant—Insomnia—Lovastatin—atherosclerosis	0.000409	0.00313	CcSEcCtD
Fulvestrant—Cough—Pravastatin—atherosclerosis	0.000409	0.00313	CcSEcCtD
Fulvestrant—ESR1—adipose tissue—atherosclerosis	0.000406	0.0301	CbGeAlD
Fulvestrant—Paraesthesia—Lovastatin—atherosclerosis	0.000406	0.00311	CcSEcCtD
Fulvestrant—Myalgia—Niacin—atherosclerosis	0.000405	0.0031	CcSEcCtD
Fulvestrant—Arthralgia—Niacin—atherosclerosis	0.000405	0.0031	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000404	0.00309	CcSEcCtD
Fulvestrant—Anorexia—Simvastatin—atherosclerosis	0.000403	0.00308	CcSEcCtD
Fulvestrant—Dyspnoea—Lovastatin—atherosclerosis	0.000403	0.00308	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000402	0.00308	CcSEcCtD
Fulvestrant—Insomnia—Ezetimibe—atherosclerosis	0.000401	0.00307	CcSEcCtD
Fulvestrant—Chest pain—Pravastatin—atherosclerosis	0.000399	0.00305	CcSEcCtD
Fulvestrant—Myalgia—Pravastatin—atherosclerosis	0.000399	0.00305	CcSEcCtD
Fulvestrant—Arthralgia—Pravastatin—atherosclerosis	0.000399	0.00305	CcSEcCtD
Fulvestrant—Paraesthesia—Ezetimibe—atherosclerosis	0.000398	0.00305	CcSEcCtD
Fulvestrant—Dyspepsia—Lovastatin—atherosclerosis	0.000398	0.00304	CcSEcCtD
Fulvestrant—Anxiety—Pravastatin—atherosclerosis	0.000397	0.00304	CcSEcCtD
Fulvestrant—Dyspnoea—Ezetimibe—atherosclerosis	0.000395	0.00302	CcSEcCtD
Fulvestrant—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000393	0.00301	CcSEcCtD
Fulvestrant—Decreased appetite—Lovastatin—atherosclerosis	0.000393	0.00301	CcSEcCtD
Fulvestrant—Dyspepsia—Ezetimibe—atherosclerosis	0.00039	0.00299	CcSEcCtD
Fulvestrant—Fatigue—Lovastatin—atherosclerosis	0.00039	0.00298	CcSEcCtD
Fulvestrant—Constipation—Lovastatin—atherosclerosis	0.000387	0.00296	CcSEcCtD
Fulvestrant—Pain—Lovastatin—atherosclerosis	0.000387	0.00296	CcSEcCtD
Fulvestrant—Decreased appetite—Ezetimibe—atherosclerosis	0.000385	0.00295	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000385	0.00295	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000383	0.00293	CcSEcCtD
Fulvestrant—Asthenia—Rosuvastatin—atherosclerosis	0.000383	0.00293	CcSEcCtD
Fulvestrant—Insomnia—Simvastatin—atherosclerosis	0.000382	0.00293	CcSEcCtD
Fulvestrant—Fatigue—Ezetimibe—atherosclerosis	0.000382	0.00292	CcSEcCtD
Fulvestrant—Infection—Pravastatin—atherosclerosis	0.00038	0.00291	CcSEcCtD
Fulvestrant—Paraesthesia—Simvastatin—atherosclerosis	0.00038	0.00291	CcSEcCtD
Fulvestrant—Pain—Ezetimibe—atherosclerosis	0.000379	0.0029	CcSEcCtD
Fulvestrant—Constipation—Ezetimibe—atherosclerosis	0.000379	0.0029	CcSEcCtD
Fulvestrant—Pruritus—Rosuvastatin—atherosclerosis	0.000377	0.00289	CcSEcCtD
Fulvestrant—Skin disorder—Niacin—atherosclerosis	0.000377	0.00289	CcSEcCtD
Fulvestrant—Dyspnoea—Simvastatin—atherosclerosis	0.000377	0.00288	CcSEcCtD
Fulvestrant—Hyperhidrosis—Niacin—atherosclerosis	0.000375	0.00287	CcSEcCtD
Fulvestrant—Dyspepsia—Simvastatin—atherosclerosis	0.000372	0.00285	CcSEcCtD
Fulvestrant—Anorexia—Niacin—atherosclerosis	0.00037	0.00283	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00037	0.00283	CcSEcCtD
Fulvestrant—Hyperhidrosis—Pravastatin—atherosclerosis	0.000369	0.00283	CcSEcCtD
Fulvestrant—Decreased appetite—Simvastatin—atherosclerosis	0.000368	0.00281	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000365	0.00279	CcSEcCtD
Fulvestrant—Diarrhoea—Rosuvastatin—atherosclerosis	0.000365	0.00279	CcSEcCtD
Fulvestrant—Fatigue—Simvastatin—atherosclerosis	0.000364	0.00279	CcSEcCtD
Fulvestrant—Anorexia—Pravastatin—atherosclerosis	0.000364	0.00279	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000363	0.00277	CcSEcCtD
Fulvestrant—Constipation—Simvastatin—atherosclerosis	0.000362	0.00277	CcSEcCtD
Fulvestrant—Pain—Simvastatin—atherosclerosis	0.000362	0.00277	CcSEcCtD
Fulvestrant—Urticaria—Lovastatin—atherosclerosis	0.000359	0.00275	CcSEcCtD
Fulvestrant—Body temperature increased—Lovastatin—atherosclerosis	0.000357	0.00273	CcSEcCtD
Fulvestrant—Abdominal pain—Lovastatin—atherosclerosis	0.000357	0.00273	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000354	0.00271	CcSEcCtD
Fulvestrant—Dizziness—Rosuvastatin—atherosclerosis	0.000353	0.0027	CcSEcCtD
Fulvestrant—Urticaria—Ezetimibe—atherosclerosis	0.000352	0.0027	CcSEcCtD
Fulvestrant—Insomnia—Niacin—atherosclerosis	0.000351	0.00269	CcSEcCtD
Fulvestrant—Abdominal pain—Ezetimibe—atherosclerosis	0.00035	0.00268	CcSEcCtD
Fulvestrant—Body temperature increased—Ezetimibe—atherosclerosis	0.00035	0.00268	CcSEcCtD
Fulvestrant—Paraesthesia—Niacin—atherosclerosis	0.000349	0.00267	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000348	0.00266	CcSEcCtD
Fulvestrant—Dyspnoea—Niacin—atherosclerosis	0.000346	0.00265	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000346	0.00265	CcSEcCtD
Fulvestrant—Insomnia—Pravastatin—atherosclerosis	0.000346	0.00265	CcSEcCtD
Fulvestrant—Paraesthesia—Pravastatin—atherosclerosis	0.000343	0.00263	CcSEcCtD
Fulvestrant—Dyspepsia—Niacin—atherosclerosis	0.000342	0.00261	CcSEcCtD
Fulvestrant—Dyspnoea—Pravastatin—atherosclerosis	0.000341	0.00261	CcSEcCtD
Fulvestrant—Decreased appetite—Niacin—atherosclerosis	0.000337	0.00258	CcSEcCtD
Fulvestrant—Dyspepsia—Pravastatin—atherosclerosis	0.000336	0.00257	CcSEcCtD
Fulvestrant—Rash—Rosuvastatin—atherosclerosis	0.000336	0.00257	CcSEcCtD
Fulvestrant—Dermatitis—Rosuvastatin—atherosclerosis	0.000336	0.00257	CcSEcCtD
Fulvestrant—Urticaria—Simvastatin—atherosclerosis	0.000336	0.00257	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Niacin—atherosclerosis	0.000335	0.00256	CcSEcCtD
Fulvestrant—Abdominal pain—Simvastatin—atherosclerosis	0.000334	0.00256	CcSEcCtD
Fulvestrant—Body temperature increased—Simvastatin—atherosclerosis	0.000334	0.00256	CcSEcCtD
Fulvestrant—Headache—Rosuvastatin—atherosclerosis	0.000334	0.00256	CcSEcCtD
Fulvestrant—Hypersensitivity—Lovastatin—atherosclerosis	0.000333	0.00255	CcSEcCtD
Fulvestrant—Decreased appetite—Pravastatin—atherosclerosis	0.000332	0.00254	CcSEcCtD
Fulvestrant—Pain—Niacin—atherosclerosis	0.000332	0.00254	CcSEcCtD
Fulvestrant—Fatigue—Pravastatin—atherosclerosis	0.00033	0.00252	CcSEcCtD
Fulvestrant—Constipation—Pravastatin—atherosclerosis	0.000327	0.0025	CcSEcCtD
Fulvestrant—Pain—Pravastatin—atherosclerosis	0.000327	0.0025	CcSEcCtD
Fulvestrant—Hypersensitivity—Ezetimibe—atherosclerosis	0.000327	0.0025	CcSEcCtD
Fulvestrant—Asthenia—Lovastatin—atherosclerosis	0.000324	0.00248	CcSEcCtD
Fulvestrant—Pruritus—Lovastatin—atherosclerosis	0.00032	0.00245	CcSEcCtD
Fulvestrant—Asthenia—Ezetimibe—atherosclerosis	0.000318	0.00243	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Niacin—atherosclerosis	0.000317	0.00243	CcSEcCtD
Fulvestrant—Nausea—Rosuvastatin—atherosclerosis	0.000317	0.00242	CcSEcCtD
Fulvestrant—Pruritus—Ezetimibe—atherosclerosis	0.000314	0.0024	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000313	0.00239	CcSEcCtD
Fulvestrant—Hypersensitivity—Simvastatin—atherosclerosis	0.000311	0.00238	CcSEcCtD
Fulvestrant—Diarrhoea—Lovastatin—atherosclerosis	0.000309	0.00237	CcSEcCtD
Fulvestrant—Urticaria—Niacin—atherosclerosis	0.000308	0.00236	CcSEcCtD
Fulvestrant—Body temperature increased—Niacin—atherosclerosis	0.000307	0.00235	CcSEcCtD
Fulvestrant—Abdominal pain—Niacin—atherosclerosis	0.000307	0.00235	CcSEcCtD
Fulvestrant—Urticaria—Pravastatin—atherosclerosis	0.000304	0.00232	CcSEcCtD
Fulvestrant—Asthenia—Simvastatin—atherosclerosis	0.000303	0.00232	CcSEcCtD
Fulvestrant—Diarrhoea—Ezetimibe—atherosclerosis	0.000303	0.00232	CcSEcCtD
Fulvestrant—Abdominal pain—Pravastatin—atherosclerosis	0.000302	0.00231	CcSEcCtD
Fulvestrant—Body temperature increased—Pravastatin—atherosclerosis	0.000302	0.00231	CcSEcCtD
Fulvestrant—Pruritus—Simvastatin—atherosclerosis	0.000299	0.00229	CcSEcCtD
Fulvestrant—Dizziness—Lovastatin—atherosclerosis	0.000299	0.00229	CcSEcCtD
Fulvestrant—Dizziness—Ezetimibe—atherosclerosis	0.000293	0.00224	CcSEcCtD
Fulvestrant—Diarrhoea—Simvastatin—atherosclerosis	0.000289	0.00221	CcSEcCtD
Fulvestrant—Vomiting—Lovastatin—atherosclerosis	0.000287	0.0022	CcSEcCtD
Fulvestrant—Hypersensitivity—Niacin—atherosclerosis	0.000286	0.00219	CcSEcCtD
Fulvestrant—ESR1—liver—atherosclerosis	0.000285	0.0211	CbGeAlD
Fulvestrant—Rash—Lovastatin—atherosclerosis	0.000285	0.00218	CcSEcCtD
Fulvestrant—Dermatitis—Lovastatin—atherosclerosis	0.000285	0.00218	CcSEcCtD
Fulvestrant—Headache—Lovastatin—atherosclerosis	0.000283	0.00217	CcSEcCtD
Fulvestrant—Vomiting—Ezetimibe—atherosclerosis	0.000282	0.00216	CcSEcCtD
Fulvestrant—Hypersensitivity—Pravastatin—atherosclerosis	0.000282	0.00215	CcSEcCtD
Fulvestrant—Dizziness—Simvastatin—atherosclerosis	0.00028	0.00214	CcSEcCtD
Fulvestrant—Rash—Ezetimibe—atherosclerosis	0.00028	0.00214	CcSEcCtD
Fulvestrant—Dermatitis—Ezetimibe—atherosclerosis	0.000279	0.00214	CcSEcCtD
Fulvestrant—Estradiol—ALB—atherosclerosis	0.000279	0.145	CrCbGaD
Fulvestrant—Asthenia—Niacin—atherosclerosis	0.000279	0.00213	CcSEcCtD
Fulvestrant—Headache—Ezetimibe—atherosclerosis	0.000278	0.00213	CcSEcCtD
Fulvestrant—Pruritus—Niacin—atherosclerosis	0.000275	0.0021	CcSEcCtD
Fulvestrant—Asthenia—Pravastatin—atherosclerosis	0.000274	0.0021	CcSEcCtD
Fulvestrant—Pruritus—Pravastatin—atherosclerosis	0.00027	0.00207	CcSEcCtD
Fulvestrant—Vomiting—Simvastatin—atherosclerosis	0.000269	0.00206	CcSEcCtD
Fulvestrant—Nausea—Lovastatin—atherosclerosis	0.000268	0.00205	CcSEcCtD
Fulvestrant—Rash—Simvastatin—atherosclerosis	0.000267	0.00204	CcSEcCtD
Fulvestrant—Dermatitis—Simvastatin—atherosclerosis	0.000266	0.00204	CcSEcCtD
Fulvestrant—Diarrhoea—Niacin—atherosclerosis	0.000266	0.00203	CcSEcCtD
Fulvestrant—Headache—Simvastatin—atherosclerosis	0.000265	0.00203	CcSEcCtD
Fulvestrant—Nausea—Ezetimibe—atherosclerosis	0.000263	0.00202	CcSEcCtD
Fulvestrant—Diarrhoea—Pravastatin—atherosclerosis	0.000262	0.002	CcSEcCtD
Fulvestrant—Dizziness—Niacin—atherosclerosis	0.000257	0.00196	CcSEcCtD
Fulvestrant—Dizziness—Pravastatin—atherosclerosis	0.000253	0.00193	CcSEcCtD
Fulvestrant—Nausea—Simvastatin—atherosclerosis	0.000251	0.00192	CcSEcCtD
Fulvestrant—Vomiting—Niacin—atherosclerosis	0.000247	0.00189	CcSEcCtD
Fulvestrant—Rash—Niacin—atherosclerosis	0.000245	0.00187	CcSEcCtD
Fulvestrant—Dermatitis—Niacin—atherosclerosis	0.000245	0.00187	CcSEcCtD
Fulvestrant—Headache—Niacin—atherosclerosis	0.000243	0.00186	CcSEcCtD
Fulvestrant—Vomiting—Pravastatin—atherosclerosis	0.000243	0.00186	CcSEcCtD
Fulvestrant—Rash—Pravastatin—atherosclerosis	0.000241	0.00184	CcSEcCtD
Fulvestrant—Dermatitis—Pravastatin—atherosclerosis	0.000241	0.00184	CcSEcCtD
Fulvestrant—Headache—Pravastatin—atherosclerosis	0.000239	0.00183	CcSEcCtD
Fulvestrant—Nausea—Niacin—atherosclerosis	0.000231	0.00176	CcSEcCtD
Fulvestrant—Nausea—Pravastatin—atherosclerosis	0.000227	0.00174	CcSEcCtD
Fulvestrant—CYP3A4—liver—atherosclerosis	0.000159	0.0118	CbGeAlD
Fulvestrant—NR1H4—Metabolism—PLA2G1B—atherosclerosis	4.99e-05	0.000384	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—atherosclerosis	4.96e-05	0.000382	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.94e-05	0.00038	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	4.94e-05	0.00038	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.93e-05	0.00038	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HMOX1—atherosclerosis	4.91e-05	0.000378	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SIRT1—atherosclerosis	4.9e-05	0.000377	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.89e-05	0.000376	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—ESR1—atherosclerosis	4.88e-05	0.000376	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.88e-05	0.000375	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALOX5—atherosclerosis	4.82e-05	0.000371	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.76e-05	0.000366	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOB—atherosclerosis	4.7e-05	0.000362	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PARP1—atherosclerosis	4.7e-05	0.000362	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.64e-05	0.000357	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.63e-05	0.000356	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.61e-05	0.000354	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA1B—atherosclerosis	4.59e-05	0.000353	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTM1—atherosclerosis	4.57e-05	0.000352	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCA1—atherosclerosis	4.57e-05	0.000352	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.52e-05	0.000348	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—LPL—atherosclerosis	4.49e-05	0.000345	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.45e-05	0.000343	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—atherosclerosis	4.45e-05	0.000343	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ESR2—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GPX1—atherosclerosis	4.38e-05	0.000337	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—atherosclerosis	4.32e-05	0.000333	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NAMPT—atherosclerosis	4.32e-05	0.000333	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.3e-05	0.000331	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LIPC—atherosclerosis	4.3e-05	0.000331	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	4.29e-05	0.00033	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PARP1—atherosclerosis	4.28e-05	0.00033	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOC3—atherosclerosis	4.27e-05	0.000329	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CD36—atherosclerosis	4.26e-05	0.000328	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LDLR—atherosclerosis	4.24e-05	0.000327	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CETP—atherosclerosis	4.14e-05	0.000319	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PARP1—atherosclerosis	4.09e-05	0.000315	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—AKT1—atherosclerosis	4.08e-05	0.000314	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARA—atherosclerosis	4.08e-05	0.000314	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—ESR2—atherosclerosis	4.06e-05	0.000312	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTHFR—atherosclerosis	4.04e-05	0.000311	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.01e-05	0.000309	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SCARB1—atherosclerosis	3.97e-05	0.000305	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARA—atherosclerosis	3.96e-05	0.000305	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—atherosclerosis	3.92e-05	0.000302	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.86e-05	0.000297	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AGT—atherosclerosis	3.84e-05	0.000295	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—AKT1—atherosclerosis	3.77e-05	0.00029	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOE—atherosclerosis	3.76e-05	0.000289	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOB—atherosclerosis	3.76e-05	0.000289	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMGCR—atherosclerosis	3.75e-05	0.000288	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CAV1—atherosclerosis	3.73e-05	0.000287	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	3.72e-05	0.000287	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOA1—atherosclerosis	3.72e-05	0.000286	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—ESR1—atherosclerosis	3.69e-05	0.000284	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—atherosclerosis	3.67e-05	0.000283	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—atherosclerosis	3.65e-05	0.000281	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—LPL—atherosclerosis	3.59e-05	0.000276	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SIRT1—atherosclerosis	3.58e-05	0.000276	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.56e-05	0.000274	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	3.55e-05	0.000273	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.54e-05	0.000273	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GPX1—atherosclerosis	3.5e-05	0.000269	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CD36—atherosclerosis	3.41e-05	0.000262	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CG—atherosclerosis	3.39e-05	0.000261	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.38e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	3.38e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—atherosclerosis	3.37e-05	0.000259	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCA1—atherosclerosis	3.34e-05	0.000257	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—atherosclerosis	3.28e-05	0.000252	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTHFR—atherosclerosis	3.23e-05	0.000249	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—INS—atherosclerosis	3.21e-05	0.000247	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK3—atherosclerosis	3.18e-05	0.000245	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARA—atherosclerosis	3.17e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SIRT1—atherosclerosis	3.12e-05	0.00024	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.09e-05	0.000237	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRH1—atherosclerosis	3.08e-05	0.000237	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AGT—atherosclerosis	3.07e-05	0.000236	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—atherosclerosis	3.03e-05	0.000234	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.03e-05	0.000233	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—atherosclerosis	3.01e-05	0.000231	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAV1—atherosclerosis	2.98e-05	0.000229	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARA—atherosclerosis	2.98e-05	0.000229	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOA1—atherosclerosis	2.97e-05	0.000229	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—atherosclerosis	2.95e-05	0.000227	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—atherosclerosis	2.87e-05	0.000221	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—atherosclerosis	2.82e-05	0.000217	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.8e-05	0.000216	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOB—atherosclerosis	2.75e-05	0.000211	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	2.72e-05	0.000209	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CG—atherosclerosis	2.71e-05	0.000209	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ESR1—atherosclerosis	2.7e-05	0.000208	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—atherosclerosis	2.67e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.65e-05	0.000204	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LPL—atherosclerosis	2.62e-05	0.000202	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—atherosclerosis	2.62e-05	0.000202	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARA—atherosclerosis	2.59e-05	0.0002	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—atherosclerosis	2.58e-05	0.000198	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.57e-05	0.000198	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INS—atherosclerosis	2.57e-05	0.000198	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GPX1—atherosclerosis	2.56e-05	0.000197	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CD36—atherosclerosis	2.49e-05	0.000192	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—atherosclerosis	2.46e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA4—atherosclerosis	2.42e-05	0.000186	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.4e-05	0.000185	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—atherosclerosis	2.36e-05	0.000182	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—atherosclerosis	2.36e-05	0.000181	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—ESR1—atherosclerosis	2.35e-05	0.000181	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—atherosclerosis	2.33e-05	0.000179	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARA—atherosclerosis	2.32e-05	0.000178	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1B—atherosclerosis	2.31e-05	0.000178	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AGT—atherosclerosis	2.24e-05	0.000173	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.24e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL4—atherosclerosis	2.23e-05	0.000171	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—atherosclerosis	2.22e-05	0.000171	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.2e-05	0.00017	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—atherosclerosis	2.2e-05	0.000169	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAV1—atherosclerosis	2.18e-05	0.000168	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—atherosclerosis	2.17e-05	0.000167	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	2.16e-05	0.000166	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	2.15e-05	0.000165	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—atherosclerosis	2.14e-05	0.000165	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA2—atherosclerosis	2.08e-05	0.00016	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PARP1—atherosclerosis	2.06e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—atherosclerosis	2.06e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	2.02e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—UTS2—atherosclerosis	1.99e-05	0.000153	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—atherosclerosis	1.98e-05	0.000153	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MAPK3—atherosclerosis	1.97e-05	0.000152	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ESR2—atherosclerosis	1.95e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—atherosclerosis	1.93e-05	0.000149	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—atherosclerosis	1.91e-05	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	1.9e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASR—atherosclerosis	1.9e-05	0.000146	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—atherosclerosis	1.88e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	1.87e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.79e-05	0.000138	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CNR2—atherosclerosis	1.77e-05	0.000136	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—atherosclerosis	1.72e-05	0.000132	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—atherosclerosis	1.65e-05	0.000127	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.59e-05	0.000122	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VWF—atherosclerosis	1.58e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—atherosclerosis	1.57e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOC3—atherosclerosis	1.57e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LDLR—atherosclerosis	1.56e-05	0.00012	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL3—atherosclerosis	1.52e-05	0.000117	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—atherosclerosis	1.51e-05	0.000116	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLTP—atherosclerosis	1.49e-05	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCF1—atherosclerosis	1.46e-05	0.000112	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MAPK3—atherosclerosis	1.44e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR2—atherosclerosis	1.38e-05	0.000106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRA—atherosclerosis	1.38e-05	0.000106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYBA—atherosclerosis	1.37e-05	0.000105	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PARP1—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GHRL—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLAT—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—atherosclerosis	1.33e-05	0.000102	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARA—atherosclerosis	1.31e-05	0.000101	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—atherosclerosis	1.3e-05	9.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.29e-05	9.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.29e-05	9.94e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MAPK3—atherosclerosis	1.26e-05	9.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KNG1—atherosclerosis	1.18e-05	9.06e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR1—atherosclerosis	1.17e-05	9.01e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLG—atherosclerosis	1.14e-05	8.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—atherosclerosis	1.08e-05	8.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.08e-05	8.31e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.04e-05	8.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.04e-05	7.99e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—atherosclerosis	1.04e-05	7.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.02e-05	7.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOB—atherosclerosis	1.01e-05	7.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—atherosclerosis	9.92e-06	7.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL5—atherosclerosis	9.84e-06	7.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—atherosclerosis	9.74e-06	7.49e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—atherosclerosis	9.73e-06	7.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LPL—atherosclerosis	9.63e-06	7.41e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FABP4—atherosclerosis	9.6e-06	7.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LCAT—atherosclerosis	9.6e-06	7.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA4—atherosclerosis	9.43e-06	7.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCG—atherosclerosis	9.36e-06	7.2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP7A1—atherosclerosis	9.26e-06	7.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPP1—atherosclerosis	9.12e-06	7.02e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.56e-06	6.59e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—atherosclerosis	8.48e-06	6.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDGFB—atherosclerosis	8.44e-06	6.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGT—atherosclerosis	8.24e-06	6.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.11e-06	6.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA2—atherosclerosis	8.11e-06	6.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.11e-06	6.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.11e-06	6.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—atherosclerosis	8.07e-06	6.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—atherosclerosis	8.07e-06	6.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.02e-06	6.17e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CAV1—atherosclerosis	7.99e-06	6.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—atherosclerosis	7.98e-06	6.14e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPA—atherosclerosis	7.74e-06	5.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—atherosclerosis	7.61e-06	5.86e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—atherosclerosis	7.57e-06	5.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BGN—atherosclerosis	7.5e-06	5.77e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA5—atherosclerosis	7.42e-06	5.71e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	7.28e-06	5.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.14e-06	5.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.9e-06	5.31e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—atherosclerosis	6.89e-06	5.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—atherosclerosis	6.78e-06	5.22e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—atherosclerosis	6.67e-06	5.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MAPK3—atherosclerosis	6.34e-06	4.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	6.33e-06	4.87e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.19e-06	4.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LIPC—atherosclerosis	6.15e-06	4.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOC3—atherosclerosis	6.11e-06	4.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LDLR—atherosclerosis	6.07e-06	4.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—atherosclerosis	6.04e-06	4.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CETP—atherosclerosis	5.93e-06	4.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.68e-06	4.37e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.37e-06	4.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—atherosclerosis	5.36e-06	4.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—atherosclerosis	4.85e-06	3.73e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKB1—atherosclerosis	4.8e-06	3.69e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.78e-06	3.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—atherosclerosis	4.72e-06	3.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—atherosclerosis	4.36e-06	3.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—atherosclerosis	4.31e-06	3.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—atherosclerosis	4.27e-06	3.29e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK3—atherosclerosis	4.12e-06	3.17e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.1e-06	3.16e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—atherosclerosis	4e-06	3.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOB—atherosclerosis	3.93e-06	3.02e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.82e-06	2.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPL—atherosclerosis	3.75e-06	2.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—atherosclerosis	3.66e-06	2.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD36—atherosclerosis	3.57e-06	2.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.38e-06	2.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARA—atherosclerosis	3.31e-06	2.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AGT—atherosclerosis	3.21e-06	2.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—atherosclerosis	3.15e-06	2.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAV1—atherosclerosis	3.12e-06	2.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—atherosclerosis	3.11e-06	2.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—atherosclerosis	3.01e-06	2.32e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.84e-06	2.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—atherosclerosis	2.78e-06	2.14e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—atherosclerosis	2.74e-06	2.11e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—atherosclerosis	2.69e-06	2.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—atherosclerosis	2.46e-06	1.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—atherosclerosis	2.36e-06	1.81e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.16e-06	1.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—atherosclerosis	1.08e-06	8.34e-06	CbGpPWpGaD
